Home | Community | Get Involved | Donate | | Site Index | Search Go Button
The mark, American Cancer Society, is a registered trademark of the American Cancer Society, Inc., and may not be copied, reproduced, transmitted, displayed, performed, distributed, sublicensed, altered, stored for subsequent use or otherwise used in whole or in part in any manner without ACS's prior written consent.
 
My Planner Register | Sign In Sign In


Treatment Topics & Resources
 
    Supporting Cancer Patients
Financial and Legal Matters
Staying Active During Treatment
Physical Changes & Appearance
    Symptoms and Side Effects
    Nutrition for Cancer Patients
    Guide to Cancer Drugs
Glossary
   
References

American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Evaluation and Treatment of Male Sexual Dysfunction: A couple's problem – 2003 Update Endocr Pract. 2003;9(No. 1).

American Cancer Society. Prostate Cancer Detailed Guide. Accessed at http://www.cancer.org/docroot/CRI/CRI_2_3x.asp?dt=36 on November 25, 2008.

American Urological Association. 2006 Annual Meeting Highlights: Erectile dysfunction. AUA News, 2006. Accessed at http://www.auanet.org/content/education-and-meetings/on-line-education/amhighlights/ed.pdf on November 18, 2008.

American Urological Association. Clinical Guidelines: Management of Erectile Dysfunction. Available at http://www.auanet.org/guidelines/edmgmt.cfm. Accessed November 18, 2008.

American Urological Association. Guideline on the Pharmacologic Management of Premature Ejaculation. Accessed at http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines/main-reports/pme/pme_2004.pdf on November 18, 2008.

Bissada NK, Yakout HH, Fahmy WE, et al. Multi-institutional long-term experience with conservative surgery for invasive penile carcinoma. J Urol. 2003 Feb;169:500-502.

Clifford D. Caring for sexuality in loss. In Wells, D. (Ed.) Caring for Sexuality in Health and Illness. Philadelphia, PA; Churchill Livingstone. 2000: 85-105.

Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151:54-61

Grover SA, Lowensteyn I, Kaouache M, et al. The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease. Arch Intern Med. 2006;3;166:213-219.

Katz A. The Sounds of Silence: sexuality information for cancer patients. J Clin Onc. 2005; 23:238-241.

Kendirci M, Hellstrom WJ. Current concepts in the management of erectile dysfunction in men with prostate cancer. Clin Prostate Cancer. 2004;3:87-92.

Knight D. Health Care Screening for Men Who Have Sex with Men. Am Fam Physician. 2004;69:2149-2156.

Markowitz LE, Dunne EF, Saraiya M, et al. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mort Wkly Rep. 2007 Mar 23;56(RR-2):1-24.

Martins FE, Rodrigues RN, Lopes TM. Organ-preserving surgery for penile carcinoma. Adv Urol. 2008. Accessed at www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=19009032 on November 24, 2008.

Meistrich ML, Vassilopoulou-Sellin R, Lipshultz LI. Gonadal Dysfunction. In DeVita VT, Hellman S, Rosenberg SA (Eds). Cancer: Principles and Practice of Oncology, 7th ed. 2005: Lippincott Williams & Wilkins, New York. 2560-2574.

Mulhall J, Land S, Parker M, et al. The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. The Journal of Sexual Medicine. 2005;2: 540-542.

National Cancer Institute. Sexuality and Reproductive Issues (PDQ®). Accessed at www.cancer.gov/cancertopics/pdq/supportivecare/sexuality/HealthProfessional on November 24, 2008.

Potosky AL, Davis WW, Hoffman RM, et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst. 2004 Sep 15;96:1358-1367.

Riscoll L. Bigger, harder, better: natural sex enhancers or Viagra-era snake oil? Contemporary Sexuality. Accessed at http://aasect.org/NEWS/may2003.asp on January 2005.

US Food and Drug Administration. International Pharmaceuticals, Ltd. Issues a Voluntary Recall of all Viril-Ity-Power (VIP) Tabs, a Product Marketed as a Dietary Supplement. Recall -- Firm Press Release, May 29, 2008. Accessed at www.fda.gov/oc/po/firmrecalls/internationalpharma05_08.html on November 24, 2008.

US Food and Drug Administration. Palo Alto Labs Issues a Voluntary Nationwide Recall of Aspire36 and Aspire Lite, two Products Marketed as Dietary Supplements. Recall -- Firm Press Release, February 20, 2008. Accessed at www.fda.gov/oc/po/firmrecalls/paloalto02_08.html on November 24, 2008.

Last Medical Review: 02/02/2009
Last Revised: 02/02/2009

Printer-Friendly Page
Email this Page
Related Tools & Topics
Learn About Cancer  
Making Treatment Decisions  
Circle Of Sharing: Personalize Your Cancer Information  
Not registered yet?
  Register now or see reasons to register.  
Help |  About ACS |  Employment & Volunteer Opportunities |  Legal & Privacy Information |  Press Room
Copyright 2009 © American Cancer Society, Inc.
All content and works posted on this website are owned and
copyrighted by the American Cancer Society, Inc. All rights reserved.